Form D — Shenandoah Therapeutics Inc.
0002068421-25-000001 · filed May 15, 2025
Offering
- Industry
- Other Technology
- Exemptions
- 06b
- Total offering
- $21,499,989
- Total sold
- $21,499,989
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Shenandoah Therapeutics Inc.
- CIK
- 2068421
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2022
- Address
- 329 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO, CA 94080 - Phone
- 650-239-0503
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Isabella Graef · Executive OfficerSouth San Francisco, CA Find on LinkedIn ↗
-
Mark Stepka · Executive OfficerSouth San Francisco, CA Find on LinkedIn ↗
-
Jim Edwards · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Gary Yeung · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Wendy Young · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Nathanael Gray · DirectorSouth San Francisco, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗